Among the primary biomarkers routinely used in clinical practice for CRC diagnosis and response monitoring are carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), and CA 125. The gene discussed is CEACAM5; the disease is colorectal carcinoma.